Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
22 April 2020updated 06 Oct 2020 9:45am

Lunchtime summary: More vaccine hope

By Samuel Horti

Yesterday, Health Secretary Matt Hancock said a government-backed team of researchers in Oxford were ready to begin testing vaccines in humans this week. Reaching that stage would normally take years, he said. This morning, the head of a research team at Imperial College London, which is also receiving government funding, was similarly upbeat, saying he was “very confident” a vaccine would be developed.

The coronavirus was fairly stable, so researchers could “lock [their[ sights” on a target, he said. “I think we are very confident that some vaccines will come through and work. There are so many groups working on different approaches and the virus is not as difficult a target as some of the things we have seen before.”

If a vaccine is made, it will also need to be distributed. This morning, we learned that Sir Andrew Witty, former chief executive of the GlaxoSmithKline, will lead a global body set up to ensure vaccines are distributed fairly.

In France, meanwhile, more than half of private sector employees are now having their wages paid by the state’s coronavirus social security scheme. 

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

And finally, confusion and contradictions continue to mount over the UK’s involvement in an EU procurement scheme for medical supplies. The government has said it missed out on the scheme because of a communication mix-up, but the EU Commission has now insisted ministers had “ample time” to sign up.